These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26890312)

  • 1. Pharmacological considerations in the use of stiripentol for the treatment of epilepsy.
    Verrotti A; Prezioso G; Stagi S; Paolino MC; Parisi P
    Expert Opin Drug Metab Toxicol; 2016; 12(3):345-52. PubMed ID: 26890312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study.
    Rosati A; Boncristiano A; Doccini V; Pugi A; Pisano T; Lenge M; De Masi S; Guerrini R
    Epilepsia; 2019 Nov; 60(11):2255-2262. PubMed ID: 31630399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stiripentol in the Management of Epilepsy.
    Nickels KC; Wirrell EC
    CNS Drugs; 2017 May; 31(5):405-416. PubMed ID: 28434133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stiripentol.
    Chiron C
    Neurotherapeutics; 2007 Jan; 4(1):123-5. PubMed ID: 17199026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stiripentol: efficacy and tolerability in children with epilepsy.
    Perez J; Chiron C; Musial C; Rey E; Blehaut H; d'Athis P; Vincent J; Dulac O
    Epilepsia; 1999 Nov; 40(11):1618-26. PubMed ID: 10565591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Starting stiripentol in adults with Dravet syndrome? Watch for ammonia and carnitine.
    Zulfiqar Ali Q; Marques P; Selvarajah A; Tabarestani S; Sadoway T; Andrade DM
    Epilepsia; 2020 Nov; 61(11):2435-2441. PubMed ID: 33084037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs.
    Stefanović S; Janković SM; Novaković M; Milosavljević M; Folić M
    Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):153-159. PubMed ID: 29268032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stiripentol open study in Japanese patients with Dravet syndrome.
    Inoue Y; Ohtsuka Y; Oguni H; Tohyama J; Baba H; Fukushima K; Ohtani H; Takahashi Y; Ikeda S
    Epilepsia; 2009 Nov; 50(11):2362-8. PubMed ID: 19552653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stiripentol: an example of antiepileptic drug development in childhood epilepsies.
    Nabbout R; Chiron C
    Eur J Paediatr Neurol; 2012 Sep; 16 Suppl 1():S13-7. PubMed ID: 22695038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stiripentol for the treatment of seizures in Dravet syndrome.
    Eschbach K; Knupp KG
    Expert Rev Clin Pharmacol; 2019 May; 12(5):379-388. PubMed ID: 31017478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels.
    Quilichini PP; Chiron C; Ben-Ari Y; Gozlan H
    Epilepsia; 2006 Apr; 47(4):704-16. PubMed ID: 16650136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stiripentol.
    Chiron C
    Expert Opin Investig Drugs; 2005 Jul; 14(7):905-11. PubMed ID: 16022579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis.
    Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Nov; 47(11):1841-54. PubMed ID: 17116023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stiripentol. A novel antiepileptic drug.
    Trojnar MK; Wojtal K; Trojnar MP; Czuczwar SJ
    Pharmacol Rep; 2005; 57(2):154-60. PubMed ID: 15886413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus.
    Grosenbaugh DK; Mott DD
    Neuropharmacology; 2013 Apr; 67():136-43. PubMed ID: 23168114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.
    Trivisano M; Specchio N; Vigevano F
    Eur J Paediatr Neurol; 2015 Mar; 19(2):248-50. PubMed ID: 25510386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stiripentol and vigabatrin current roles in the treatment of epilepsy.
    Chiron C
    Expert Opin Pharmacother; 2016 Jun; 17(8):1091-101. PubMed ID: 26933940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stiripentol for the treatment of seizures associated with Dravet syndrome.
    Chiron C
    Expert Rev Neurother; 2019 Apr; 19(4):301-310. PubMed ID: 30900478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stiripentol for the treatment of super-refractory status epilepticus.
    Strzelczyk A; Kortland LM; Knake S; Rosenow F
    Acta Neurol Scand; 2015 Dec; 132(6):435-9. PubMed ID: 25809474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stiripentol: A Review in Dravet Syndrome.
    Frampton JE
    Drugs; 2019 Nov; 79(16):1785-1796. PubMed ID: 31617141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.